Beth Israel Deaconess Medical Center Expands Partnership with Pfizer’s Centers for Therapeutic Innovation to Include Focus on Small Molecule Drug Targets
Beth Israel Deaconess Medical Center (BIDMC) announced today the expansion of its partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) into the identification and development of small-molecule drug candidates. This agreement, the...
12/4/2013 3:55 PM EST
In recent years, research has suggested that carbon monoxide, the highly toxic gas emitted from auto exhausts and faulty heating systems, can be used to treat certain inflammatory medical conditions. Now a study led by a research team at Beth...
12/4/2013 2:55 PM EST
A new pilot study led by researchers at Beth Israel Deaconess Medical Center suggests that the brain changes associated with meditation and stress reduction may play an important role in slowing the progression of age-related cognitive disorders...
11/18/2013 1:00 PM EST
A new study led by investigators at Beth Israel Deaconess Medical Center finds that, on average, 30 percent of all lab tests are probably unnecessary -- and equally as many necessary tests may be going unordered.
11/14/2013 10:00 AM EST
A comprehensive analysis of more than 1 million hospital admissions finds that over 50 percent of all nonsurgical patients were prescribed opioids during their hospitalizations -- often at very high doses.
11/11/2013 10:00 AM EST
As the link between type 2 diabetes and dementia becomes more widely recognized, new findings from Beth Israel Deaconess Medical Center offer promise of a new treatment for this growing problem.
11/13/2013 1:30 PM EST
A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV.
10/25/2013 10:00 AM EDT
The considerable diversity of HIV worldwide represents a critical challenge for designing an effective HIV vaccine. Now a scientific team led by Beth Israel Deaconess Medical Center shows that mosaic antigens might overcome this challenge.
10/21/2013 1:00 PM EDT